rs200153557
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003803.4(MYOM1):c.1813C>G(p.Leu605Val) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003803.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYOM1 | ENST00000356443.9 | c.1813C>G | p.Leu605Val | missense_variant | Exon 12 of 38 | 1 | NM_003803.4 | ENSP00000348821.4 | ||
| MYOM1 | ENST00000261606.11 | c.1813C>G | p.Leu605Val | missense_variant | Exon 12 of 37 | 1 | ENSP00000261606.7 |
Frequencies
GnomAD3 genomes AF: 0.000670 AC: 102AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000213 AC: 53AN: 249100 AF XY: 0.000148 show subpopulations
GnomAD4 exome AF: 0.0000725 AC: 106AN: 1461504Hom.: 0 Cov.: 30 AF XY: 0.0000633 AC XY: 46AN XY: 727030 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000670 AC: 102AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000524 AC XY: 39AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.L605V variant (also known as c.1813C>G), located in coding exon 11 of the MYOM1 gene, results from a C to G substitution at nucleotide position 1813. The leucine at codon 605 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at